Form D · Biotechnology
INSMED INC
Richmond, VA · CIK 0001104506
Offering snapshot reported Dec 15, 2010 · SEC filing
- Reported sold
- $83.7M Offering amount: $83.7M
- Investors reported
- 33 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2010 | Initial | $83,720,903 | No comparison | 33 | SEC filing |
| Mar 23, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-151930
Represents the agreed upon value of the shares issued pursuant to the Agreement and Plan of Merger based on the 30 day average trading price for the Issuer's common stock for the 30 trading days ending November 30, 2010.
Source: Form D, filed Dec 15, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steinar Engelsen | Director |
| Renu Gupta | Executive |
| Donald Hayden, Jr. | Director |
| Nicholas La Bella | Executive |
| Melvin Sharoky | Director |
| Kevin P Tully | Executive |
| Randall Whitcomb | Director |
| Timothy Whitten | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8720 Stony Point Parkway Suite 200
Richmond, VA, 23235
Richmond, VA, 23235